JPRN-UMIN000030164
Completed
未知
Monitoring EGFR mutation status with cell-free DNA: a prospective exploratory analyses of phase Ib study of osimertinib plus ramucirumab in lung adenocarcinoma patients with EGFR T790M mutation - Exploratory analyses of Phase Ib study of osimertinib with ramucirumab
Conditionsung Cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- ung Cancer
- Sponsor
- Wakayama Medical University
- Enrollment
- 3
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Study on the detection of EGFR mutation using the high sensitive PCR method in lung cancerJPRN-UMIN000033567Shizuoka Cancer Center50
Completed
Not Applicable
Exploratory study on detecting EGFR mutation including T790M with blood samples from patients with advanced non-small cell lung cancer after EGFR-TKI failureAdvanced non-small cell lung cancer with EGFR mutationJPRN-UMIN000021860Shizuoka cancer center120
Completed
Not Applicable
An observational study of EGFR mutation status by circulating tumor DNA during the osimertinib treatment of lung cancer harboring EGFR activating and T790M mutations.lung CancerJPRN-UMIN000025278Miyagi Cancer Center60
Recruiting
Not Applicable
EGFR-mutation analysis of circulating tumor DNA with high sensitive methods and concordance to effect of EGFR-TKI.JPRN-UMIN000016348Miyagi Cancer Center30
Completed
Not Applicable
Exploratory study of detection of mutated EGFR from plasma of patients with EGFR mutant non-small cell lung cancer resistant to EGFR-TKI.JPRN-UMIN000007817Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital26